论文部分内容阅读
制药产业是我国国民经济的重要组成部分,制药产业的良好发展不仅关乎人民群众的健康保障,也是国家实力的体现。随着社会经济的发展,我国制药产业的规模、数量都在不断攀升,但在这背后,我国制药产业发展与国外相比还存在巨大的差距,国际间竞争力也严重不足,许多医药界的专业人士都对此高度关注。为此,北京大学国家发展研究院李玲教授就医改过程中我国制药产业陷入的误区,提出了自己的看法。为何我国药品在国际上没有竞争力“
The pharmaceutical industry is an important part of our national economy. The sound development of the pharmaceutical industry is not only related to the people’s health protection, but also reflects the strength of the country. With the development of society and economy, the scale and quantity of China’s pharmaceutical industry are constantly rising. However, behind this, there is still a huge gap between the development of China’s pharmaceutical industry and that of other countries. The international competitiveness is also seriously insufficient. Many professionals in the pharmaceutical industry People are highly concerned about this. To this end, Professor Li Ling from National Institute of Development of Peking University put forward his own views on the misunderstanding that China’s pharmaceutical industry caught in the medical reform process. Why China’s pharmaceuticals are not internationally competitive? ”